Table 6 Stratified survival analysis of e2f-1 expression in groups with different TNM stage
From: Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma
TNM groups | Grouping (month) | e2f-1 expression (n/%) | χ2value | P 1 value* | χ2value | P 2 value# | |
|---|---|---|---|---|---|---|---|
Positive | Negative | ||||||
Stage I-II | < 20 | 19/36.5 | 9/17.3 | 4.792 | 0.029 | -0.304 | 0.029 |
≥ 20 | 9/17.3 | 15/28.8 | |||||
Stage III-IV | < 20 | 10/14.5 | 37/53.6 | 2.895 | 0.081 | 0.205 | 0.091 |
≥ 20 | 9/13.0 | 13/18.8 | |||||